MENU
+Compare
JDOC
ETF ticker: NASDAQ
AS OF
Nov 13, 10:30 AM (EDT)
Price
$57.16
Change
+$0.39 (+0.69%)
Net Assets
8.58M

JDOC stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Health
JDOC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for JDOC with price predictions
Nov 12, 2025

Aroon Indicator for JDOC shows an upward move is likely

JDOC's Aroon Indicator triggered a bullish signal on November 05, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 110 similar instances where the Aroon Indicator showed a similar pattern. In of the 110 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on JDOC as a result. In of 30 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for JDOC moved out of overbought territory on October 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for JDOC turned negative on October 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 19 similar instances when the indicator turned negative. In of the 19 cases the stock turned lower in the days that followed. This puts the odds of success at .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Intuitive Surgical (NASDAQ:ISRG), Amgen (NASDAQ:AMGN), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT).

Industry description

The investment seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.

Market Cap

The average market capitalization across the JPMorgan Healthcare Leaders ETF ETF is 87.98B. The market cap for tickers in the group ranges from 841.55M to 910.93B. LLY holds the highest valuation in this group at 910.93B. The lowest valued company is BHVN at 841.55M.

High and low price notable news

The average weekly price growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was 10%. For the same ETF, the average monthly price growth was 38%, and the average quarterly price growth was 160%. PEN experienced the highest price growth at 24%, while BHVN experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was -12%. For the same stocks of the ETF, the average monthly volume growth was 38% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 59
Price Growth Rating: 44
SMR Rating: 61
Profit Risk Rating: 65
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
JDOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
J.P. Morgan Exchange-Traded Fund Trust270 Park AvenueNew York
Phone
(800) 480-4111
Web
N/A